Germany Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Germany Drug Delivery Devices market is expected to register a 7.6% CAGR during the forecast period. Some of the primary factors that are responsible for the tremendous growth of this market are the growing burden of chronic disorders in the country and advancing technology in drug delivery devices.

Germany has presence of all the major pharmaceuticals and biotechnology companies. The companies are constantly taking initiatives to introduce new products in order to grow their presence in the market. For instance, in July 2019, Sensile Gerresheimer subsidiary Sensile Medical developed D Mine Pump which is a wearable microinfusion pump and used for administering apomorphine in the Parkinson's treatment. Thus, owing to such innovations the market is expected to boost over the forecast period. However, the manufacturing of a complex drug delivery system is quite lengthy which might have a negative impact on the market.

Key Market TrendsCancer is Expected to Show a Significant Growth in the Market during the Forecast Period

Cancer in the applications segment is expected to contribute significantly to the growth of the market, owing to factors such as the rising number of cancer cases being reported in the country. According to the estimates of the Globocan 2018, there are about 608,742 new cases of cancer in Germany. While five most frequent cancers include breast, lung, prostate, colorectum, and bladder cancer. Due to this high prevalence of cancer, increasing efforts are being made in R&D for the development of novel drug delivery systems for providing a better treatment in the patients. The use of innovative technologies in drug deliveries for cancer treatment is driving the market in this segment.

Drug delivery systems like nano-size structures-based pharmaceutical formulations (e.g., liposomes, polymeric nanoparticles, electrosprayed particles, and nanosuspension) have demonstrated shown better administration of drugs in case of cancer treatment. Thus, overall a positive growth is expected in this segment during the forecast period.

Competitive Landscape

Some of the companies which are currently dominating the Germany Drug Delivery Devices market are Pfizer Inc., 3M, Phillips-Medisize - a Molex Company, Novartis AG, Novaliq GmbH, Acino International AG, Bayer AG and Boehringer Ingelheim. In March 2019, Boehringer Ingelheim acquired ICD Therapeutics for the company's MacroDel biologics-delivery platform. This is expected to open up opportunities for the treatment of cancers that are difficult to treat.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Pfizer Inc.
3M Company
Phillips
Medisize
a Molex Company
Novartis AG
Novaliq GmbH
Acino International AG
Bayer AG
Boehringer Ingelheim

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.